hotspot -WSS

hotspot

author：focus 2025-10-01 02:12:35 - browse：83

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： RSV injection headlines need to be accurate for good uptake

focus

WSS

Congress extends some pandemic preparedness programs

WHO recommends second malaria vaccine

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Stop Congress from blocking public access to science

First recipient of genetically engineered pig kidney has died

The Karikó problem: Lessons for funding basic research

Wikipedia

hotspot

focus

The high cost of giving birth even with insurance

What will Novo Nordisk's VC do with its influx of cash?

BioMarin wins approval for gene therapy to treat hemophilia A

CDC picks Alphabet's Verily for wasterwater surveillance contract

Cancer drug shortages should be causing more outrage

The biotech scorecard for Q4: 16 stock

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Apple Watch's A

Psychedelics group wrestles with new pharma identity

After gene therapy, two congenitally deaf children hear for the first time

explore

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Lawsuit highlights wrinkle for disputes over surprise medical bills

Dairy farmers resist CDC push for PPE against bird flu virus

Medicare innovation center doesn’t save money, experts say

Medicare innovation center doesn’t save money, experts say

Lawsuit highlights wrinkle for disputes over surprise medical bills

focus

hotspot

explore

focus